As a member of the European Paediatric and Adolescent Cancer Community, I call for the following items: 1. ACCESS TO ANTI-CANCER MEDICINES AND INNOVATION FOR CHILDREN AND ADOLESCENTS Faster and more efficient development of innovative medicines for children with cancer - including in relation to the EU Paediatric Regulation: based on European Parliament Resolution on Paediatric Medicines, Dec.
Institut Curie
Academic / research · France
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
Counts here are a floor, never a total: they cover the 687 consultation files tracked so far (60,344 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Institut in PolicySpeak: request access →
Work at Institut Curie? so we know who speaks for it.
Their record over time
Institut Curie filed 2 positions between 1 Mar 2020 and 23 Feb 2026, across 2 of the 687 legislative files tracked here.
What they argued
As a life science research institution, we welcome the Commissions commitment to promoting gender equality in research and innovation and the progress made through measures such as mandatory Gender Equality Plans and the requirement to address sex and gender dimensions already at proposal stage.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Institut Curie next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Is this your organization?
Everything on this page comes from Institut Curie’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.